The multinational pharmaceutical giant AstraZeneca drew immediate backlash Friday for announcing an end to its pledge not to profit from its publicly funded coronavirus vaccine until the end of the pandemic, which is still killing more than 7,000 people worldwide each day.
Developed in partnership with the University of Oxford, the AstraZeneca vaccine was almost entirely financed by taxpayers and charitable trusts, with just around 2% of the money coming from private industry.
Nick Dearden, director of the U.K.-based advocacy group Global Justice Now, said in a statement that “AstraZeneca’s decision to start profiting from Oxford University’s coronavirus vaccine mid-pandemic shows the utter folly of giving away publicly funded science to Big Pharma.”
“The non-profit pledge was never a gift to the world from a benevolent company,” said Dearden. “It was the most Oxford could get from a manufacturer playing hardball during a global health emergency. And AstraZeneca has still refused to share the vaccine recipe with the [World Health Organization], which would allow poorer countries to manufacture it for themselves.”
“This moment was always going to come — and it’s exactly why public health experts have demanded a waiver of intellectual property on Covid-19 vaccines,” he continued. “Corporations will always put profits first if you give them control over who lives and who dies.”
In a press release on Friday, AstraZeneca said it expects to “progressively transition the vaccine to modest profitability as new orders are received.” The company said the shot generated just over $1 billion in revenue in the third quarter.
The Financial Times reported that AstraZeneca’s shot will “remain non-profit for developing countries,” but the company’s contract with the University of Oxford gives it the ability to charge some low-income nations higher prices once it decides the pandemic has ended.
Pascal Soriot, AstraZeneca’s CEO, claimed Friday that Covid-19 “is becoming endemic, which means we have to learn to live with it.”
BREAKING 📢 @AstraZeneca break their COVID-19 vaccine promise in pursuit of profit.
We are saddened, we are angry. The pandemic is not over. Call for a #PeoplesVaccine for EVERYONE, everywhere.
Read our full response here:https://t.co/ZY22LqLZew
— The People’s Vaccine (@peoplesvaccine) November 12, 2021
According to a recent report by Amnesty International, AstraZeneca has delivered more coronavirus vaccine doses to lower-income countries than its major competitors, including Pfizer and Moderna — both of which reported major vaccine profits in the third quarter. AstraZeneca has also “issued some voluntary licenses to other manufacturers,” the humanitarian group observed.
“However,” Amnesty noted, “it has refused to openly share its knowledge and technology with WHO initiatives and has opposed” India and South Africa’s proposed patent waiver.
Anna Marriott, health policy manager at Oxfam International, said in a statement Friday that AstraZeneca is “breaking its repeated and celebrated public promises of a non-profit vaccine for all countries for the duration of this pandemic and to never to make a profit in any low- and middle-income country from this publicly funded vaccine.”
“Broken promises from pharmaceutical corporations and rich country governments have been an enduring theme of this pandemic when it comes to vaccine access,” Marriott added. “This is a further example of why the U.K. government can no longer defend the pharmaceutical monopolies driving today’s vaccine apartheid.”
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.